Skip to content
ppharmaranks
Menu

BRYNOVIN vs TRADJENTA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 17, 2026·How we rate

Possible drug interaction. BRYNOVIN and TRADJENTA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Rating

70/100
72/100

Pharmacy pays

~$110.51 /30

Type

RX
RX

Active ingredient

SITAGLIPTIN HYDROCHLORIDE
LINAGLIPTIN

Dosage forms

Solution
Tablet

Drug class

Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitor

Boxed warning

None
None

Half-life

about 12.4 hours (apparent terminal half-life after a single 100 mg oral dose in healthy volunteers)
about 200 hours — the terminal (elimination) half-life at steady state, per the label

Treats

Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus

Get tradjentahigher-rated option

Advertising disclosure: Some links are affiliate links. We may earn a commission at no extra cost to you. This never affects our independent ratings.

Get treatment online

Licensed online providers — consult & get prescribed if eligible.

Frequently asked questions

Which is better-rated, Brynovin or Tradjenta?

By our independent rating, Tradjenta scores higher — 3.6 vs 3.5 out of 5 for Brynovin. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Brynovin and Tradjenta?

Brynovin contains Sitagliptin Hydrochloride, while Tradjenta contains Linagliptin — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.